INTRODUCTION
The therapeutic strategy of venous leg ulcers is based on two complementary elements: compression therapy and topical care with dressings that promote the healing process. Two prospective multicenter phase III clinical trials were conducted to assess the performance (efficacy, tolerance and acceptability) of a new type of foam wound dressing in the treatment of leg ulcers.
MATERIALS AND METHODS
Both non-comparative, open label clinical trials were conducted in 30 investigating centers that included Hospital Dermatology, Vascular Medicine Departments and private physicians. Non-Adhesive (NA) and Adhesive (A) wound foams, used in these studies, had a non-adherent wound contact layer containing petrolatum formulation and hydrocolloid particles, and a protective polyurethane backing. The Adhesive version was framed by an adhesive tape. The NA wound foam had a useful surface area of 100%, meaning that it may be cut according to the wound surface.
These clinical trials included patients presenting venous or mixed leg ulcers (ABI ≥ 0.8). Subjects were treated for 6 weeks with the study dressing, and were evaluated weekly (clinical evaluation, planimetric and photographic records). 43 and 50 patients were enrolled in the Non-Adhesive and Adhesive clinical trials, respectively. The primary endpoint of these trials was represented by the reduction of the wound surface area after the 6 week treatment. 
RESULTS
The baseline characteristics of the treated leg ulcers of two studies are documented in Table I . The dressings were removed on average every 3.21 ±1.83 days (NA) and 2.9 ±1.6 days (A), respectively.
After 6 weeks of treatment, the mean surface area was reduced of 37.9% (NA) and 46.8% (A) respectively (Graph 1). After completing the 6 weeks of treatment, the investigators considered that the wounds were clinically improved in 73% (NA) and 72% (A), respectively.
Compression therapy was combined with Non-Adhesive wound foam in 87% of the patients and in 90% with Adhesive wound foam.
Acceptability was evaluated by the nursing staff each time the dressing was changed (Table II) . Nursing staff noted that Non Adhesive (NA) and Adhesive (A) wound foams were very easy to use (dressing application and removal) and the patients particularly appreciated their pain-free removal (Table II) .
DISCUSSION-CONCLUSION
The analysis of the clinical trials appeared to show that the Non-Adhesive (NA) and Adhesive (A) wound foams were effective, safe and very well accepted. The Non-Adhesive wound dressing was particularly suited to use with fragile and/or impaired peri-lesional skin. The compatibility of both foam dressings with the use of compression therapy suggests that Non-Adhesive (NA) and Adhesive (A) wound foams play a valuable role in the treatment of exudating venous and mixed leg ulcers. Salt Lake City, Utah
